Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-568.8%
operating margin TTM
-554.71%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -2.87 |
| peg ratio | -0.01 |
| price to book ratio | 2.80 |
| price to sales ratio | 20.50 |
| enterprise value multiple | -5.57 |
| price fair value | 2.80 |
profitability ratios | |
|---|---|
| gross profit margin | 81.22% |
| operating profit margin | -554.71% |
| pretax profit margin | -568.98% |
| net profit margin | -568.8% |
| return on assets | -35.62% |
| return on equity | -63.05% |
| return on capital employed | -37.61% |
liquidity ratios | |
|---|---|
| current ratio | 11.30 |
| quick ratio | 11.02 |
| cash ratio | 10.07 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 674.81 |
| operating cycle | 721.96 |
| days of payables outstanding | 482.50 |
| cash conversion cycle | 239.46 |
| receivables turnover | 7.74 |
| payables turnover | 0.76 |
| inventory turnover | 0.54 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.31 |
| debt equity ratio | 0.50 |
| long term debt to capitalization | 0.33 |
| total debt to capitalization | 0.33 |
| interest coverage | -10.06 |
| cash flow to debt ratio | -1.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.66 |
| cash per share | 1.65 |
| operating cash flow per share | -0.66 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.08 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) reported earnings?
X4 Pharmaceuticals, Inc. (XFOR) published its most recent earnings results on 06-08-2026.
What is X4 Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. X4 Pharmaceuticals, Inc. (NASDAQ:XFOR)'s trailing twelve months ROE is -63.05%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. X4 Pharmaceuticals, Inc. (XFOR) currently has a ROA of -35.62%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did XFOR's net profit margin stand at?
XFOR reported a profit margin of -568.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is XFOR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 11.30 in the most recent quarter. The quick ratio stood at 11.02, with a Debt/Eq ratio of 0.50.